Elm Pollen Allergy: A Spring Trigger from a Widespread North American Tree
Elm pollen allergy is a springtime respiratory condition triggered by pollen from trees in the Ulmus genus, which are widespread across North America. It affects millions of Americans, particularly in the Midwest and Northeast where American elm populations are dense, with peak pollen release from February through April. Symptoms include sneezing, nasal congestion, itchy eyes, and asthma exacerbations. Evidence-based management combines antihistamines, intranasal corticosteroids, and allergen immunotherapy, which can modify the underlying disease.
Free · 5 min · Insurance accepted
What Is Elm Pollen Allergy?
Elm pollen allergy is an immune-mediated reaction to the pollen released by trees in the Ulmus genus, a group of deciduous hardwoods found throughout the Northern Hemisphere.
In North America, six native elm species — including the iconic American elm (Ulmus americana), slippery elm (Ulmus rubra), and rock elm (Ulmus thomasii) — produce significant quantities of wind-borne pollen each spring. Elm pollen is a well-characterized aeroallergen, with its allergenic proteins documented in clinical literature for decades.
Elm trees are anemophilous, meaning they rely on wind for pollination rather than insects. This adaptation results in the production of vast quantities of lightweight, dry pollen grains designed to travel long distances through the air. For sensitized individuals, inhalation of these grains triggers an IgE-mediated allergic cascade that produces the classic symptoms of seasonal allergic rhinitis, commonly known as hay fever. Unlike some regionally restricted tree pollens, elm pollen allergy is relevant across most of the continental United States and southern Canada, wherever elm species are present in the urban or natural canopy.
Symptoms of Elm Pollen Allergy
Recognizing symptoms early helps you get the right treatment faster.
Sneezing
moderateFrequent, repetitive sneezing is often the earliest and most prominent symptom of elm pollen exposure, triggered by histamine release in the nasal mucosa.
Nasal congestion
moderateSwelling of the nasal turbinates from histamine-driven vasodilation causes blockage and difficulty breathing through the nose, often worsening at night.
Clear rhinorrhea
mildProfuse watery nasal discharge is a hallmark of IgE-mediated allergic rhinitis, distinct from the thick, discolored mucus of infectious sinusitis.
Itchy, watery eyes
moderateBilateral allergic conjunctivitis with intense itching, tearing, and conjunctival injection is common during peak elm pollen exposure.
Palatal and ear itching
mildDeep itching of the soft palate and inner ears is a characteristic feature of pollen allergy, mediated by histamine release in the shared sensory innervation of the upper airway.
Cough and wheeze
severeIn sensitized patients with asthma, elm pollen inhalation can trigger bronchoconstriction, producing cough, wheezing, and chest tightness that may require bronchodilator use.
Fatigue and impaired concentration
mildChronic nasal congestion disrupts sleep quality, while persistent allergic inflammation contributes to daytime fatigue and reduced cognitive performance during the pollen season.
When to see a doctor
Elm pollen allergy produces the classic symptom complex of seasonal allergic rhinitis, with manifestations affecting the upper and lower airways and the eyes. The most common symptoms are paroxysmal sneezing, nasal congestion, clear rhinorrhea, and intense nasal and palatal itching. Ocular symptoms — including bilateral itchy, watery, and red eyes — are nearly universal in pollen-sensitized patients and can be particularly bothersome during peak pollen days. Because elm pollen grains are small (approximately 30 micrometers in diameter) and capable of penetrating into the lower airways, sensitized patients with underlying asthma may experience cough, wheezing, chest tightness, and shortness of breath during the elm bloom period. This lower airway involvement distinguishes clinically significant pollen allergy from milder forms and warrants proactive asthma management during the spring season. Fatigue, irritability, and impaired concentration — often described as "brain fog" — are common secondary effects of poorly controlled allergic rhinitis and disrupted sleep from nocturnal nasal congestion. If you experience difficulty breathing, chest tightness, or wheezing that does not respond to your usual medications, seek medical attention promptly.
Elm Pollen and Asthma Risk
The relationship between elm pollen allergy and asthma is well-established within the broader framework of allergic airway disease. Patients with allergic rhinitis — including those sensitized to elm pollen — have approximately a threefold increased risk of developing asthma compared to non-atopic individuals. Elm pollen grains, at roughly 30 micrometers in diameter, are small enough to reach the lower airways, where they can trigger IgE-mediated bronchoconstriction in sensitized patients. During the February–April elm bloom, patients with known asthma may experience increased symptoms, reduced peak expiratory flow rates, and greater reliance on rescue bronchodilators. For patients who have not yet been diagnosed with asthma but notice chest tightness or wheezing during the spring pollen season, evaluation by a board-certified allergist is recommended to assess for pollen-induced asthma and optimize treatment.
Potential Complications of Elm Pollen Allergy
Untreated or poorly controlled elm pollen allergy can lead to several clinically significant complications over time. Chronic nasal inflammation impairs mucociliary clearance, creating conditions that predispose to recurrent acute sinusitis and, in some patients, chronic sinusitis requiring prolonged treatment. The inflammatory burden of persistent allergic rhinitis is also a recognized risk factor for the development of new-onset asthma, a progression sometimes described as the atopic march. Sleep disturbance from nocturnal nasal congestion is common and can lead to daytime somnolence, reduced work productivity, and impaired academic performance in children and adolescents. Patients with elm pollen allergy who are also sensitized to profilins — pan-allergens found across tree, grass, and weed pollens — may develop oral allergy syndrome with certain raw fruits and vegetables, adding dietary complexity to their condition. In rare cases, patients with severe, uncontrolled asthma triggered by pollen exposure may experience asthma exacerbations requiring emergency department visits or hospitalization.
Recurrent or chronic sinusitis
Persistent nasal mucosal inflammation can obstruct sinus ostia, leading to recurrent acute bacterial sinusitis or chronic sinusitis requiring extended antibiotic courses or surgical intervention.
Asthma development or exacerbation
Untreated allergic rhinitis is a major risk factor for new-onset asthma, and existing asthma may worsen significantly during the elm pollen season without adequate control.
Sleep disturbance
Nocturnal nasal congestion disrupts sleep architecture, causing daytime fatigue, impaired concentration, and reduced quality of life during the pollen season.
Oral allergy syndrome
Patients with profilin sensitization may experience oral itching and mild swelling when eating raw fruits and vegetables that contain cross-reactive profilins.
What Causes Elm Pollen Reactions?
Elm pollen allergy is caused by an IgE-mediated hypersensitivity to proteins present in elm pollen grains. When a genetically susceptible individual is repeatedly exposed to elm pollen, their immune system may mistakenly identify certain pollen proteins as harmful, producing specific IgE antibodies against them. On subsequent exposures, these IgE antibodies bind to mast cells in the nasal mucosa and conjunctiva, triggering degranulation and the release of histamine, leukotrienes, and other inflammatory mediators that produce the symptoms of allergic rhinitis.
American elm
Ulmus americana
Slippery elm
Ulmus rubra
Rock elm
Ulmus thomasii
Siberian elm
Ulmus pumila
Chinese elm / lacebark elm
Ulmus parvifolia
How it works
Elm pollen allergy follows the classic Type I (IgE-mediated) hypersensitivity pathway. Initial sensitization occurs when antigen-presenting cells process elm pollen proteins and present them to T-helper cells, which drive B-cells to produce elm-specific IgE antibodies. These antibodies attach to high-affinity receptors on mast cells and basophils. Upon re-exposure, elm pollen allergens cross-link adjacent IgE molecules on the mast cell surface, triggering immediate degranulation with release of preformed histamine and newly synthesized leukotrienes and prostaglandins. This produces the rapid-onset sneezing, itching, and congestion characteristic of seasonal allergic rhinitis, typically within minutes of pollen exposure.
While specific allergenic proteins from elm pollen have been less extensively characterized at the molecular level compared to birch (Bet v 1) or ragweed (Amb a 1), elm pollen is known to contain profilins and other pan-allergens that can contribute to cross-reactivity with other tree, grass, and weed pollens. This means that patients sensitized to elm may also react to pollens from other trees, particularly those in the Ulmaceae family or related orders. The clinical significance of elm pollen as a primary sensitizer versus a cross-reactive trigger depends on the individual patient's sensitization profile and geographic exposure patterns.
Risk factors to watch for
Geographic location
Residents of the Midwest, Northeast, and Great Plains regions of the United States have the highest ambient exposure to elm pollen due to dense native and ornamental elm populations.
Personal or family history of atopy
Individuals with a personal or family history of allergic rhinitis, asthma, or atopic dermatitis have a significantly elevated risk of developing elm pollen sensitization.
Existing tree pollen sensitization
Patients already sensitized to other spring-blooming trees such as birch, oak, or maple may be at increased risk for co-sensitization to elm pollen through shared pan-allergen profiles.
Outdoor occupation or recreation
Landscapers, arborists, gardeners, and individuals who spend significant time outdoors during the February–April elm bloom period face higher cumulative pollen exposure.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
How to Diagnose Elm Pollen Allergy
Diagnosing elm pollen allergy begins with a detailed clinical history that establishes the seasonal pattern of symptoms and their correlation with local pollen counts. A patient who reports sneezing, nasal congestion, and itchy eyes that begin in February or March and resolve by May — particularly in the Midwest or Northeast — has a history highly suggestive of early-spring tree pollen allergy, with elm as a likely contributor. Objective testing confirms the diagnosis. Skin prick testing, in which a small amount of standardized elm pollen extract is introduced into the superficial dermis, produces a wheal-and-flare response within 15–20 minutes in sensitized individuals. Serum-specific IgE testing offers an alternative for patients who cannot discontinue antihistamines or who have extensive skin disease. Because elm pollen allergy frequently co-exists with sensitization to other spring-blooming trees — including maple, oak, birch, and ash — a comprehensive regional tree pollen panel is recommended rather than testing for elm in isolation. At-home allergy testing services such as Curex provide panels covering 40+ environmental allergens with results typically within 5 days, allowing patients to map their full spring pollen sensitization profile before the season begins.
Skin prick test with tree pollen panel
Standardized elm pollen extract is applied to the forearm or back via a small lancet prick. A positive wheal (≥3mm larger than negative control) at 15–20 minutes indicates IgE sensitization. Regional tree panels including maple, oak, birch, and ash are tested simultaneously.
Specific IgE blood testing (ImmunoCAP)
Serum IgE antibodies to elm pollen and other regional tree pollens are measured quantitatively, providing a sensitization profile without the need for skin testing.
Nasal allergen challenge
In research settings, controlled intranasal administration of elm pollen extract can confirm clinical reactivity, but this is rarely performed outside academic allergy centers.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizTreatment Options for Elm Pollen Allergy
See how different approaches stack up for managing your allergy symptoms long-term.
Treatment for elm pollen allergy follows the evidence-based stepwise approach recommended for all seasonal allergic rhinitis. First-line therapy combines allergen avoidance strategies with pharmacotherapy tailored to symptom severity. For mild, intermittent symptoms, second-generation oral antihistamines provide rapid relief of sneezing, itching, and rhinorrhea. For patients with moderate-to-severe symptoms — particularly those with significant nasal congestion — intranasal corticosteroids are the most effective single-agent therapy and are recommended as first-line treatment by current guidelines.
Patients whose symptoms are not adequately controlled with pharmacotherapy, or who wish to reduce long-term medication dependence, may be candidates for allergen immunotherapy. Both subcutaneous immunotherapy (allergy shots) and sublingual immunotherapy (allergy drops) have demonstrated efficacy in reducing symptoms and medication requirements for tree pollen allergy, with benefits that persist after treatment completion. The choice between these modalities depends on patient preference, lifestyle factors, and shared decision-making with a board-certified allergist.
Pollen avoidance strategies
Reducing elm pollen exposure by keeping windows closed during peak season, using HEPA air filtration indoors, showering after outdoor activities, and monitoring local pollen counts to plan outdoor time.
Not applicable
Partial symptom reduction; complete avoidance is not feasible during spring pollen season
Second-generation oral antihistamines
Non-sedating H1 receptor antagonists reduce sneezing, itching, and rhinorrhea; most effective when taken daily during the pollen season rather than as-needed.
Zyrtec (cetirizine), Claritin (loratadine), Allegra (fexofenadine), Xyzal (levocetirizine)
Clinical studies demonstrate 50–60% reduction in rhinitis symptom scores with regular use
Intranasal corticosteroids
First-line therapy for moderate-to-severe allergic rhinitis; reduce nasal mucosal inflammation, congestion, and all nasal symptoms more effectively than antihistamines alone.
Flonase (fluticasone), Nasonex (mometasone), Nasacort (triamcinolone), Rhinocort (budesonide)
Meta-analyses show 30–40% greater total symptom reduction compared to oral antihistamine monotherapy
Antihistamine eye drops
Topical ophthalmic antihistamines and mast cell stabilizers provide rapid, targeted relief of allergic conjunctivitis symptoms that may persist despite oral medications.
Pataday (olopatadine), Alaway (ketotifen), Lastacaft (alcaftadine)
Rapid onset of action (minutes) with effective control of ocular itching, redness, and tearing
Allergen immunotherapy (SCIT or SLIT)
Disease-modifying treatment that gradually desensitizes the immune system to elm and other tree pollens through regular administration of standardized allergen extracts over 3–5 years.
Standardized tree pollen allergen extracts including elm, administered as subcutaneous injections (SCIT) or sublingual drops (SLIT)
Clinical trials demonstrate 60–80% reduction in seasonal symptoms and medication requirements with sustained benefit after treatment completion
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Immunotherapy for Elm Pollen Allergy
Instead of masking symptoms, immunotherapy retrains your immune system.
For patients whose elm pollen allergy symptoms are not adequately controlled with pharmacotherapy — or who wish to address the underlying immune dysfunction rather than simply suppress symptoms — allergen immunotherapy offers a disease-modifying approach. Both subcutaneous immunotherapy (allergy shots) and sublingual immunotherapy (allergy drops) have demonstrated efficacy for tree pollen allergy, with clinical trials showing 60–80% reduction in seasonal symptoms and medication requirements. Subcutaneous immunotherapy involves regular injections of gradually increasing doses of standardized elm pollen extract (often combined with other regionally relevant tree pollens) administered in a medical setting under allergist supervision. The build-up phase typically requires weekly visits for several months, followed by monthly maintenance injections for 3–5 years. Sublingual immunotherapy, offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing), delivers custom-formulated allergen drops under the tongue and can be taken at home — eliminating the need for weekly clinic visits. In a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy, peer-reviewed in Frontiers in Allergy, clinically meaningful symptom improvement rose to 45% of patients by two years and quality-of-life improvement reached 90.7%, with adherence over 90% and no reported anaphylaxis. Both modalities induce a shift from IgE-driven allergic responses toward IgG4-mediated tolerance, with benefits that persist for years after treatment completion. The choice between SCIT and SLIT should be made in consultation with a board-certified allergist, considering factors such as patient preference, travel logistics, and insurance coverage.
Comprehensive allergy testing
Confirm elm pollen sensitization and identify any co-sensitizations to other spring tree pollens (maple, oak, birch, ash) that should be included in the immunotherapy formulation.
Custom extract formulation
A board-certified allergist prescribes a personalized immunotherapy extract containing elm and any other clinically relevant tree pollens at appropriate therapeutic doses.
Build-up phase
Gradually increasing doses of allergen extract are administered over several months to induce immune tolerance without triggering significant allergic reactions.
Maintenance phase and long-term tolerance
Once the therapeutic maintenance dose is reached, treatment continues for 3–5 years to establish durable immune tolerance that persists after treatment completion.
“Clinical trials demonstrate 60–80% reduction in seasonal allergy symptoms and medication requirements with allergen immunotherapy for tree pollen allergy”
Treat your Elm Pollen allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing · Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living With Elm Pollen Sensitivity
Living with elm pollen sensitivity is manageable with a proactive, multi-pronged approach that combines environmental control, appropriate pharmacotherapy, and — for suitable candidates — disease-modifying immunotherapy. The key to successful management is anticipating the elm pollen season before it begins. Because elm is one of the earliest trees to pollinate, often starting in February before most patients are thinking about spring allergies, having medications ready and environmental controls in place by late January can prevent the severe early-season symptoms that are difficult to control once inflammation is established. For patients in the Midwest and Northeast — where American elm populations remain significant despite Dutch elm disease — the elm pollen season overlaps with maple, oak, and birch seasons, creating a cumulative pollen burden that can extend symptoms from February through May. Understanding this sequential pattern allows patients and their allergists to plan treatment strategies that cover the full spring season rather than targeting elm in isolation. Keeping a symptom diary correlated with local pollen counts can help identify which trees are the primary drivers of symptoms and guide immunotherapy formulation.
Plan for the early start
Elm pollen is among the earliest spring allergens, often beginning in February. Have medications on hand and environmental controls in place by late January to prevent the initial inflammatory surge that is hardest to control once established.
Understand your full spring pollen profile
Elm rarely acts alone — it overlaps with maple, oak, birch, and ash pollen seasons. Comprehensive testing through an allergist reveals the complete picture and enables immunotherapy that covers all clinically relevant spring triggers.
Use layered protection on high-count days
On days when elm pollen counts are forecast to be high, combine strategies: take your antihistamine in the morning, use your nasal spray as prescribed, wear wraparound sunglasses outdoors, and shower after returning inside.
When Does Elm Pollen Peak?
Elm pollen season is one of the earliest tree pollen seasons in North America, typically beginning in late winter and extending through mid-spring. In the southern United States, elm trees may begin pollinating as early as late January or early February, while in northern regions and Canada, the season typically starts in March and continues through April. The American elm (Ulmus americana) and slippery elm (Ulmus rubra) are among the first trees to flower each year, often releasing pollen before leaves emerge. Elm pollen counts tend to be highest during the morning hours, particularly on dry, windy days when pollen grains are readily dispersed. Rain suppresses airborne pollen concentrations by washing grains out of the air, providing temporary relief for sensitized individuals. The relatively short but intense pollination period — typically four to six weeks — means that patients experience a concentrated burst of symptoms that may overlap with the start of other tree pollen seasons, including maple, oak, and birch, creating a cumulative pollen burden in mid-spring.
February - March
medium intensity
March - April
high intensity
Late April - May
low intensity
Preventing Elm Pollen Reactions
Preventing elm pollen reactions centers on reducing exposure during the February–April bloom period and proactively managing the allergic response before symptoms escalate. The most effective environmental strategy is minimizing outdoor time during peak pollen hours — typically mid-morning through early afternoon on dry, windy days — and keeping windows and doors closed to prevent pollen infiltration into the home and vehicle. Indoor air quality can be significantly improved by using high-efficiency particulate air (HEPA) filtration in the bedroom and main living areas, and by running air conditioning rather than opening windows during the pollen season. After spending time outdoors, showering and changing clothes removes pollen that has accumulated on hair, skin, and fabric, reducing continued indoor exposure. For patients with known elm pollen allergy, starting intranasal corticosteroids 1–2 weeks before the anticipated start of the elm bloom — typically in late January or early February in most regions — can significantly reduce the severity of the initial inflammatory response and improve overall seasonal control.
Monitor local pollen counts
Use the National Allergy Bureau or a weather app with pollen tracking to identify high elm pollen days and plan outdoor activities for lower-count periods, such as after rain.
Keep windows and doors closed
During the February–April elm bloom, keep home and car windows closed and use air conditioning with HEPA filtration to maintain low indoor pollen levels.
Shower and change after outdoor exposure
Pollen clings to hair, skin, and clothing; showering and changing clothes after time outdoors removes this reservoir and prevents ongoing indoor exposure.
Start medications before the season
Beginning intranasal corticosteroids 1–2 weeks before the expected start of elm pollen release primes the nasal mucosa and reduces the severity of the initial allergic response.
Use HEPA air filtration indoors
Portable HEPA air purifiers in the bedroom and main living areas can reduce indoor pollen concentrations by capturing airborne grains before they are inhaled.
Outlook for Elm Pollen Allergy
The prognosis for elm pollen allergy is generally favorable with appropriate management. Most patients achieve adequate symptom control with a combination of environmental avoidance and pharmacotherapy during the February–April pollen season. For patients with moderate-to-severe symptoms who pursue allergen immunotherapy, clinical trials demonstrate that 60–80% experience significant, sustained reduction in seasonal symptoms and medication requirements, with benefits that persist for years after completing a 3–5 year treatment course. Elm pollen allergy does not typically progress to more severe forms of allergic disease on its own, though untreated allergic rhinitis is a recognized risk factor for the development of asthma. Early diagnosis, comprehensive testing to identify all relevant spring pollen sensitizations, and proactive management — including consideration of immunotherapy for appropriate candidates — provide the best long-term outcomes. The seasonal nature of elm pollen allergy means that most patients experience complete symptom resolution outside the February–April window, allowing for a normal quality of life for the majority of the year.
Key takeaways
Elm pollen allergy is a well-characterized spring trigger affecting millions of Americans, particularly in the Midwest and Northeast
Symptoms are seasonal and predictable, peaking February–April, allowing for proactive pre-season treatment planning
Pharmacotherapy with intranasal corticosteroids and antihistamines provides effective symptom control for most patients
Allergen immunotherapy offers disease-modifying treatment with 60–80% long-term symptom reduction and sustained benefit after treatment completion
Diet and Elm Pollen Cross-Reactivity
Dietary cross-reactivity is a consideration for some patients with elm pollen allergy, though it is less extensively characterized than the well-known birch pollen–food cross-reactivity syndromes. Elm pollen contains profilins, which are pan-allergens found across virtually all plant pollens and many plant foods. Patients sensitized to elm pollen profilins may experience oral allergy syndrome — mild tingling, itching, or swelling of the lips, mouth, and throat — when eating raw fruits and vegetables that contain structurally similar profilins. Common triggers include melons, celery, and stone fruits. These reactions are typically mild and self-limited, resolving within minutes without treatment. Cooking denatures profilins, so cooked versions of the same foods are usually well-tolerated. Patients who experience oral symptoms with raw plant foods should discuss this with their allergist to determine whether profilin sensitization is the likely mechanism and to receive guidance on dietary management.
Foods to limit
Raw melons (profilin-sensitized patients)
Melons contain profilins that may cross-react with elm pollen profilins, causing oral tingling and mild swelling in sensitized individuals.
Raw celery (profilin-sensitized patients)
Celery profilins share structural similarity with pollen profilins and may trigger oral allergy syndrome in patients with profilin-mediated elm pollen sensitization.
Raw stone fruits (profilin-sensitized patients)
Peach, nectarine, and plum contain profilins that may cause mild oral symptoms; cooking typically eliminates reactivity.
Frequently Asked Questions
Elm pollen season in the United States typically begins in late winter and extends through mid-spring, with timing varying by latitude. In the southern US, elm trees may start pollinating as early as late January or early February, while in the Northeast and Midwest, the season generally runs from March through April. Elm is one of the earliest trees to flower each year, often releasing pollen before leaves emerge. Peak pollen counts usually occur during the morning hours on dry, windy days. The season typically lasts four to six weeks, though this can vary based on local weather conditions and the specific elm species present in a given region. Patients can track local elm pollen counts through the National Allergy Bureau or weather apps with pollen forecasting features.
Medical References
- [1]American College of Allergy, Asthma & Immunology. Tree Pollen Allergy. ACAAI, 2023.
- [2]AAAAI. "Outdoor Allergens."
- [3]Mayo Clinic. Seasonal allergies: Nip them in the bud. Mayo Clinic, 2023.
- [4]Cleveland Clinic. Allergic Rhinitis (Hay Fever). Cleveland Clinic, 2023.
- [5]D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007;62(9):976–990.
- [6]MedlinePlus (U.S. National Library of Medicine). Hay Fever (Pollen Allergy). NIH.
- [7]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [8]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Elm Pollen allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.
